Single-dose genetic medicine halts the progression of ALS and frontotemporal dementia in mice

  • Post author:
  • Post category:uncategorized

Neuroscientists at Macquarie University in Australia have developed a single-dose genetic medicine that has been proven to halt the progression of both ALS and frontotemporal dementia (FTD) in mice – and may even offer the potential to reverse some of the effects of the fatal diseases.